Cerus Corporation (CERS) vs NeuroPace, Inc. (NPCE)
Cerus Corporation and NeuroPace, Inc. are both Medical Devices companies. Cerus Corporation and NeuroPace, Inc. are of similar size ($524.0M and $479.5M). NeuroPace, Inc. grew revenue faster over the last twelve months: 21.7% against 14.6%. Cerus Corporation has the higher net margin (−2.73% vs −18.6%) and the higher return on invested capital (−1.27% vs −44.6%). Across the 18 metrics below, Cerus Corporation leads on 13 and NeuroPace, Inc. on 5.
Valuation
Profitability
| Metric | CERS | NPCE | Medical Devices median |
|---|---|---|---|
| Gross margin | 57.16% | 78.38% | 56.01% |
| Operating margin | (0.65%) | (13.33%) | (15.03%) |
| Net margin | (2.73%) | (18.58%) | (20.40%) |
| Free cash flow margin | (0.74%) | (11.29%) | (7.24%) |
| Return on equity | (10.69%) | (122.05%) | (15.32%) |
| Return on assets | (3.24%) | (18.82%) | (19.72%) |
| Return on invested capital | (1.27%) | (44.64%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack